Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting Conditions

This study has been completed.
Information provided by:
Actavis Inc. Identifier:
First received: March 17, 2009
Last updated: August 13, 2010
Last verified: August 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2001
  Primary Completion Date: February 2001 (Final data collection date for primary outcome measure)